https://www.fastcompany.com/91517107/i-interv...p-long-run
Rob Barrow, CEO of Definium Therapeutics
“The U.S. is facing a profound and worsening mental health crisis, with current treatment options failing millions of people. Our big bet: to usher in a new era of psychiatry with the potential of lysergide tartrate, or LSD, which had its start in systematic research in the 1940s. Through the lens of modern science, our rigorous clinical trials are designed to explore and generate regulatory-grade evidence, and we believe we’re approaching a meaningful shift in what mental health treatment could look like. This will require deep education and collaboration across many stakeholders to create lasting change, but we’re excited and emboldened by the opportunity.”